Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cyrat

2013 ◽  
Vol 58 (4) ◽  
pp. 768-781 ◽  
Author(s):  
Naser H. M. Ibrahim ◽  
Yong Jia ◽  
Jessay G. Devassy ◽  
Tamio Yamaguchi ◽  
Harold M. Aukema
Keyword(s):  
Fish Oil ◽  
Soy Protein ◽  
Polycystic Kidneys ◽  
Lipoxygenase Products

scholarly journals Lack of Benefit of Early Intervention with Dietary Flax and Fish Oil and Soy Protein in Orthologous Rodent Models of Human Hereditary Polycystic Kidney Disease

PLoS ONE ◽  
2016 ◽  
Vol 11 (5) ◽  
pp. e0155790 ◽  
Author(s):  
Tamio Yamaguchi ◽  
Jessay G. Devassy ◽  
Md Monirujjaman ◽  
Melissa Gabbs ◽  
Harold M. Aukema
Keyword(s):  
Early Intervention ◽  
Kidney Disease ◽  
Fish Oil ◽  
Polycystic Kidney Disease ◽  
Soy Protein ◽  
Rodent Models ◽  
Polycystic Kidney

scholarly journals Nitric oxide enhancement and blood pressure decrease in patients with metabolic syndrome using soy protein or fish oil

2010 ◽  
Vol 54 (6) ◽  
pp. 540-545 ◽  
Author(s):  
Andréa Name Colado Simão ◽  
Marcell Alysson Batisti Lozovoy ◽  
Tathiana Name Colado Simão ◽  
Jane Bandeira Dichi ◽  
Tiemi Matsuo ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Fatty Acids ◽  
Fish Oil ◽  
Soy Protein ◽  
Diastolic Pressure ◽  
Blood Pressure Reduction ◽  
Systolic Pressure ◽  
Randomized Design

OBJECTIVE: To verify the effects of fish oil and soy on nitric oxide (NO) and blood pressure in patients with metabolic syndrome (MS). SUBJECTS AND METHODS: Sixty women with MS were investigated in a parallel randomized design study. The first group maintained their usual diet; the second group received 25 g/day of soy; the third group received 3 g/day of n-3 fatty acids, and the fourth group the same amount previously cited of n-3 fatty acids and soy. RESULTS: Serum nitric oxide metabolites showed significant increase after 90 days in the fish oil and soy groups. Systolic pressure reduced after 45 days of treatment with fish oil, whereas diastolic pressure decreased significantly throughout the study in the soy group. CONCLUSIONS: NO increase and blood pressure reduction with fish oil or soy protein reinforce the importance of the influence of NO on blood pressure in patients with MS.

Encapsulation optimization and pH- and temperature-stability of the complex coacervation between soy protein isolate and inulin entrapping fish oil

LWT ◽  
2019 ◽  
Vol 116 ◽  
pp. 108555 ◽  
Author(s):  
Juan D. Rios-Mera ◽  
Erick Saldaña ◽  
Yhosep Ramírez ◽  
Erick A. Auquiñivín ◽  
Izabela D. Alvim ◽  
...  
Keyword(s):  
Fish Oil ◽  
Soy Protein ◽  
Soy Protein Isolate ◽  
Temperature Stability ◽  
Protein Isolate ◽  
Complex Coacervation

scholarly journals Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil

2018 ◽  
Vol 19 (12) ◽  
pp. 4107 ◽  
Author(s):  
Tomomi Yamazaki ◽  
Dongyang Li ◽  
Reina Ikaga
Keyword(s):  
Fatty Liver ◽  
Fish Oil ◽  
Soy Protein ◽  
De Novo ◽  
Regulatory Element ◽  
De Novo Lipogenesis ◽  
Peroxisome Proliferator ◽  
Experimental Conditions ◽  
Alcoholic Fatty Liver ◽  
Food Ingredients

Obesity is prevalent in modern society because of a lifestyle consisting of high dietary fat and sucrose consumption combined with little exercise. Among the consequences of obesity are the emerging epidemics of hepatic steatosis and nonalcoholic fatty liver disease (NAFLD). Sterol regulatory element-binding protein-1c (SREBP-1c) is a transcription factor that stimulates gene expression related to de novo lipogenesis in the liver. In response to a high-fat diet, the expression of peroxisome proliferator-activated receptor (PPAR) γ2, another nuclear receptor, is increased, which leads to the development of NAFLD. β-Conglycinin, a soy protein, prevents NAFLD induced by diets high in sucrose/fructose or fat by decreasing the expression and function of these nuclear receptors. β-Conglycinin also improves NAFLD via the same mechanism as for prevention. Fish oil contains n-3 polyunsaturated fatty acids such as eicosapentaenoic acid and docosahexaenoic acid. Fish oil is more effective at preventing NAFLD induced by sucrose/fructose because SREBP-1c activity is inhibited. However, the effect of fish oil on NAFLD induced by fat is controversial because fish oil further increases PPARγ2 expression, depending upon the experimental conditions. Alcohol intake also causes an alcoholic fatty liver, which is induced by increased SREBP-1c and PPARγ2 expression and decreased PPARα expression. β-Conglycinin and fish oil are effective at preventing alcoholic fatty liver because β-conglycinin decreases the function of SREBP-1c and PPARγ2, and fish oil decreases the function of SREBP-1c and increases that of PPARα.

Sign in / Sign up

Export Citation Format

Share Document